Archive


Category: Ajovy

  • NICE backs Lilly’s Emgality for migraine, adding pressure on Novartis rival

    UK cost-effectiveness agency NICE has said that Eli Lilly’s Emgality can be made available through the NHS for migraine prevention, the second drug in the CGRP inhibitor class to achieve that milestone. The decision means that with two CGRP antibodies now cleared for migraine prevention, the first drug in the class to be approved in […]

  • Drugs for Migraine

    Date:  October 5, 2020 Issue #:  1608 Summary:  An oral nonopioid analgesic is often sufficient for acute treatment of mild to moderate migraine headache without severe nausea or vomiting. A triptan is the drug of choice for treatment of moderate to severe migraine headache pain in most patients without vascular disease. Early treatment of pain […]